148 research outputs found

    Recent developments in the molecular biology of pain

    Get PDF
    Research in understanding the molecular basis of pain has accelerated in the last twenty years. Beside the description of the ‘chemical soup’ and their receptors in chronic pain, the cloning and role of the TRP (Transient Receptor Potential) channels was also discovered, making the synthesis of new agonists and antagonists possible. However the organism itself is able to antagonize pain by activating endogenous opioid and cannabinoid receptors. New pathways in pain therapy might evolve by exploring these molecular mechanisms further

    Die Fauna des mittleren Gaults von Algermissen / von A. Wollemann

    Get PDF

    Die Bivalven und Gastropoden des norddeutschen Gaults (Aptiens und Albiens) / von A. Wollemann

    Get PDF

    Substance P induces gastric mucosal protection at supraspinal level via increasing the level of endomorphin-2 in rats.

    Get PDF
    The aim of the present study was to analyze the potential role of substance P (SP) in gastric mucosal defense and to clarify the receptors and mechanisms that may be involved in it. Gastric ulceration was induced by oral administration of acidified ethanol in male Wistar rats. Mucosal levels of calcitonin gene-related peptide (CGRP) and somatostatin were determined by radioimmunoassay. For analysis of gastric motor activity the rubber balloon method was used. We found that central (intracerebroventricular) injection of SP (9.3-74pmol) dose-dependently inhibited the formation of ethanol-induced ulcers, while intravenously injected SP (0.37-7.4nmol/kg) had no effect. The mucosal protective effect of SP was inhibited by pretreatment with neurokinin 1-, neurokinin 2-, neurokinin 3- and mu-opioid receptor antagonists, while delta- and kappa-opioid receptor antagonists had no effect. Endomorphin-2 antiserum also antagonized the SP-induced mucosal protection. In the gastroprotective dose range SP failed to influence the gastric motor activity. Inhibition of muscarinic cholinergic receptors, or the synthesis of nitric oxide or prostaglandins significantly reduced the effect of SP. In addition, centrally injected SP reversed the ethanol-induced reduction of gastric mucosal CGRP content. It can be concluded, that SP may induce gastric mucosal protection initiated centrally. Its protective effect is likely to be mediated by endomorphin-2, and vagal nerve may convey the centrally initiated protection to the periphery, where both prostaglandins, nitric oxide and CGRP are involved in mediating this effect
    corecore